Furthermore, our in vivo growth assays showed that cancer cells overexpressing LDHBWT grew quicker than cells overexpressing LDHBK329Q, whereas the growth advantage induced by LDHBWT was blocked by the presence of SIRT5 inhibitor GW5074. Here, SIRT5 is linked to cancer.